Tae-Hwan Kwon Selected Research

Breast Neoplasms (Breast Cancer)

5/2022	Aquaporin-5 in breast cancer.
1/2020	Exosomes co-expressing AQP5-targeting miRNAs and IL-4 receptor-binding peptide inhibit the migration of human breast cancer cells.
1/2019	The emerging role of xanthine oxidase inhibition for suppression of breast cancer cell migration and metastasis associated with hypercholesterolemia.
11/2017	Immunohistochemical evalulation of activated Ras and Rac1 as potential downstream effectors of aquaporin-5 in breast cancer in vivo.
2/2014	AQP5 expression predicts survival in patients with early breast cancer.
1/2011	Aquaporin-5: a marker protein for proliferation and migration of human breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tae-Hwan Kwon Research Topics

Disease

17	Nephrogenic Diabetes Insipidus 01/2020 - 12/2003
12	Polyuria 01/2018 - 01/2002
9	Neoplasms (Cancer) 05/2022 - 01/2007
8	Ureteral Obstruction 01/2019 - 11/2003
6	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2011
6	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 12/2003
5	Fibrosis (Cirrhosis) 05/2023 - 11/2005
5	Acidosis 01/2014 - 03/2003
4	Ischemia 01/2021 - 08/2004
3	Inflammation (Inflammations) 01/2021 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2019 - 10/2016
3	Mood Disorders (Mood Disorder) 01/2018 - 02/2010
3	Chronic Renal Insufficiency 07/2014 - 11/2010
3	Heart Failure 09/2013 - 01/2002
3	Diabetes Insipidus 06/2007 - 05/2005
3	Hypercalcemia (Milk Alkali Syndrome) 03/2004 - 01/2002
2	Kidney Diseases (Kidney Disease) 01/2021 - 11/2018
2	Sepsis (Septicemia) 11/2020 - 08/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2019
2	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2013 - 05/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 09/2013 - 11/2005
2	Chronic Kidney Failure (Chronic Renal Failure) 09/2013 - 04/2005
2	Azotemia 11/2010 - 04/2005
2	Shock 11/2010 - 12/2003
2	Proteinuria 11/2010 - 05/2004
2	Bone Resorption 05/2010 - 02/2009
2	Brain Ischemia (Cerebral Ischemia) 11/2008 - 10/2007
2	Ascites 11/2005 - 05/2004
2	Hypertrophy 04/2005 - 01/2004
1	Endotoxemia 11/2020
1	Hemorrhage 11/2020
1	Body Weight (Weight, Body) 01/2020
1	Autoimmune Diseases of the Nervous System 01/2020
1	Hypercholesterolemia 01/2019
1	Obesity 01/2019

Drug/Important Bio-Agent (IBA)

16	LithiumIBA 01/2020 - 12/2003
13	SodiumIBA 09/2015 - 03/2003
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
8	Aquaporin 2IBA 06/2019 - 01/2004
8	AldosteroneIBA 01/2018 - 12/2002
8	Aquaporins (Water Channels)IBA 10/2016 - 12/2002
6	Aquaporin 5IBA 05/2022 - 01/2011
4	Therapeutic UsesIBA 01/2021 - 01/2019
4	Peptides (Polypeptides)IBA 01/2020 - 01/2007
4	Vasopressins (Vasopressin)IBA 09/2015 - 01/2002
4	Messenger RNA (mRNA)IBA 10/2011 - 01/2004
3	CytokinesIBA 11/2020 - 06/2014
3	EnzymesIBA 01/2020 - 12/2007
3	Dinoprostone (PGE2)FDA Link 01/2019 - 05/2005
3	Tamoxifen FDA LinkGeneric 01/2019 - 01/2018
3	CreatinineIBA 07/2014 - 12/2003
3	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 10/2011 - 06/2007
3	salicylhydroxamic acid (SHAM)IBA 11/2010 - 12/2003
3	Adenosine Triphosphatases (ATPase)IBA 02/2009 - 01/2004
3	Fluorescein (Funduscein)FDA LinkGeneric 11/2008 - 01/2007
3	Epithelial Sodium ChannelsIBA 05/2008 - 11/2005
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2011
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2018
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2020 - 10/2008
2	ChemokinesIBA 07/2014 - 06/2014
2	AcidsIBA 01/2012 - 08/2009
2	SymportersIBA 05/2010 - 11/2005
2	Angiotensin IIIBA 12/2009 - 04/2005
2	Hormones (Hormone)IBA 05/2008 - 02/2006
2	Transforming Growth Factor beta (TGF-beta)IBA 05/2007 - 09/2003
2	Erythropoietin FDA Link 05/2007 - 08/2004
2	alpha-MSHIBA 02/2006 - 08/2004
2	Vitamin D FDA LinkGeneric 12/2002 - 01/2002
1	fisetinIBA 05/2023
1	FlavonoidsIBA 05/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	theasinensin AIBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	PolymersIBA 01/2021
1	allithiamineIBA 11/2020
1	Thiamine (Aneurin)FDA Link 11/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020
1	Myelin Basic ProteinIBA 01/2020
1	etomoxirIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	TransferasesIBA 01/2020
1	CollagenIBA 01/2019
1	CholesterolIBA 01/2019
1	hydroxide ionIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	butaprostIBA 01/2019
1	Allopurinol (Remid)FDA LinkGeneric 01/2019
1	Xanthine OxidaseIBA 01/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	Febuxostat FDA Link 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2018
1	SuspensionsIBA 11/2018
1	Bile Acids and Salts (Bile Acids)IBA 11/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2007
2	Intravenous Administration 01/2021 - 11/2008
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021